The KLHL14 gene frequently undergoes inactivating mutations in mature B cell malignancies, particularly in the MYD88 L265P, CD79B mutant (MCD) subtype of DLBCL, which heavily relies on BCR signaling for survival [102]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.